Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1100 participants
OBSERVATIONAL
2022-07-12
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
International Rare And Severe Psoriasis Expert Network
NCT04359394
Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
NCT05855460
Assessment of PD-1 and PD-L1Tissue Expression Levels in Lichen Planus Patients: A Case-Control Study
NCT04892381
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292
Assessment of the Rosacea Prevalence in the General Population
NCT02292797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A Scientific Committee validates the scientific writing, a Steering Committee supervises the clinical operations of the project.
Collected data are managed by the DACIMA Clinical Suite®, the electronic data capture platform which complies with the FDA 21 CFR part 11 requirements (Food and Drug Administration 21 Code of Federal Regulations part 11), the HIPAA specifications (Health Insurance Portability and Accountability Act), and the ICH standards (International Conference on Harmonisation). A local authorization by the National Agency of Personal Data Protection will be obtained prior to study kick-off.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed and written consent
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société Tunisienne de Dermatologie et de Vénéréologie
UNKNOWN
Dacima Consulting
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Houda Hammami, MD
Role: STUDY_CHAIR
University Hospital of Habib Thameur, Ben Arous, Tunisia
Mohamed Denguezli, MD
Role: STUDY_CHAIR
University Hospital of Farhat Hached, Sousse, Tunisia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Société Tunisienne de Dermatologie et de Vénéréologie
Tunis, Tunisia, Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Facebook page of "Société Tunisienne de Dermatologie et de Vénéréologie"
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DAC-010-PSOTREG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.